The Boston Globe published an article recently about how some drug manufacturers are pricing their drugs into the stratosphere. The article observed:
Last month, a group of prominent doctors and scientists objected to a $259,000 annual price set by Boston’s Vertex Pharmaceuticals Inc. for a new cystic fibrosis drug. The same week, in a medical journal, more than 100 leading oncologists protested a rise in cancer drug prices.
Are they kidding me? $259,000 annually for a drug?
Yes, of course, pharmaceutical companies should be allowed to make a profit, but $259,000 annually for a drug?
Somewhere, some time ago, we lost our value system. We lost our sense of values that anyone would think that this is okay.
